Dominion Aesthetic Technologies Inc reported on Tuesday the receipt of US FDA clearance for its medical, non-contact body contouring product, eon FR.
The company added that the eon FR is capable of reducing fat over a larger surface area than its competitors, which is highly desired by both physicians and patients. The body shaping technology delivers non-contact, laser energy to reduce fat in the abdomen using a patent-pending powered articulated arm.
According to the company, the eon FR causes the death of fat cells through apoptosis process that takes from six to 12 weeks and after the eon FR body contouring treatment, the body naturally eliminates fat cells through its lymphatic system. The treatment takes about 15 minutes to perform with no downtime.
Headquartered in San Antonio, TX, the laser-based medical device company offers the best innovative tools to serve the physicians' practices and the patients' needs.
Creo Medical secures FDA clearance for SpydrBlade Flex in US market
Tissue Regenix secures CE and UKCA certifications for OrthoPure XT
Terumo Corporation expands stroke portfolio in EMEA with SOFIA Flow 88 catheter launch
Crossject advances ZENEO manufacturing with scalable aseptic filling module ahead of product rollout
Mindray unveils BeneVision V Series at Euroanaesthesia 2025, advancing precision monitoring
Unicon Pharma and VRR Life Sciences partner support digital transformation in life sciences
Median Technologies submits 510(k) application for eyonis LCS lung cancer screening software
Tristel secures FDA clearance for Ophthalmic Disinfectant Tristel OPH